Cardiovascular disease (CVD) risk assessment and prognosis in otherwise healthy people is an important part of disease management. Early detection and diagnosis of CVD, supported by the extensive health data on the condition already stored in hospital systems, has the ability to greatly improve disease outcomes. Clinical practice for the management of Cardiovascular Diseases (CVDs) stands to benefit greatly from the use of machine learning approaches. Patients and the healthcare system can save money thanks to these methods, which can be used to create evidence-based clinical guidelines and management algorithms. This will cut down on expensive and time-consuming clinical and laboratory examinations. This study suggests creating new deep learning algorithms that can automatically identify important variables and detect early-stage heart disease; these algorithms should be resilient, effective, efficient, and unique in order to improve early anticipation and interference for CVDs. An F1-score of around 89% is produced by the suggested Catboost model. Hence, it outperformed numerous other state-of-the-art methods by maximizing classification efficiency with better correctness and precision.
No takes yet. Share an insight, caveat, or question.
Rani et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: